Ipsen announces its corporate agenda for 2018

15 February 2018: Full year 2017 sales & results
26 April 2018: First quarter 2018 sales
30 May 2018: General shareholders’ meeting
6 June 2018: Payment of 2017 dividend**
26 July 2018: First half 2018 sales & results
25 October 2018: First nine months 2018 sales

* This financial calendar is for indicative purposes only and the Group could change its publication dates should it deem it necessary
** Pending approval of the Board of Directors of 14 February 2018 and of the General shareholders’ meeting of 30 May 2018

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2019